Nanoscope Therapeutics to Showcase Innovative Retinal Therapies at Eyecelerator and AAO Annual Meeting 2026 #USA #New_Orleans #Nanoscope #MOGENRY #AAO2026

Nanoscope Therapeutics Advances MOGENRY® for Inherited Retinal Dystrophies in Japan with Priority Review #Japan #Tokyo #Nanoscope #MOGENRY® #IRD

Nanoscope Therapeutics to Showcase Groundbreaking Data on Macular Degeneration and Retinitis Pigmentosa at Euretina Congress 2026 #USA #Dallas #Nanoscope #retinitis_pigmentosa #MOGENRY

Nanoscope Therapeutics Reveals Exciting MCO-010 Data at Retina Society Meeting #United_States #Los_Angeles #Nanoscope #MCO-010 #Retina_Society

Nanoscope Therapeutics to Showcase Innovations at the 28th Annual H.C. Wainwright Global Investment Conference #USA #New_York #biotechnology #Nanoscope #MOGENRY

Nanoscope Therapeutics Achieves Critical FDA Milestone for MOGENRY to Treat Severe Vision Loss #United_States #Dallas #Nanoscope #retinitis_pigmentosa #MOGENRY